Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board accepts TAC recommendation not to add BCKDK to newborn panel; adopts updated review criteria
Summary
The Washington State Board of Health accepted its newborn screening technical advisory committee's recommendation not to add BCKDK deficiency to the mandatory newborn screening panel and voted to adopt revised criteria the TAC will use for future condition reviews, including a new public-health-readiness item.
The Washington State Board of Health accepted a technical advisory committee recommendation not to add branched chain ketoacid dehydrogenase kinase (BCKDK) deficiency to Washington’s mandatory newborn screening panel and approved updated criteria the committee will use to evaluate future candidate conditions.
The board voted to accept the TAC recommendation after the newborn screening technical advisory committee reviewed limited evidence about BCKDK — a rare genetic disorder associated with epilepsy, autism and intellectual disability — and found insufficient data on screening test performance, diagnostic follow-up and outcomes to support adding it to the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
